GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Short-Term Capital Lease Obligation

BioLife Solutions (STU:BJX1) Short-Term Capital Lease Obligation : €1.70 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is BioLife Solutions Short-Term Capital Lease Obligation?

BioLife Solutions's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was €1.70 Mil.

BioLife Solutions's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (€2.80 Mil) to Dec. 2024 (€1.44 Mil) but then increased from Dec. 2024 (€1.44 Mil) to Mar. 2025 (€1.70 Mil).

BioLife Solutions's annual Short-Term Capital Lease Obligation declined from Dec. 2022 (€2.85 Mil) to Dec. 2023 (€1.18 Mil) but then increased from Dec. 2023 (€1.18 Mil) to Dec. 2024 (€1.44 Mil).


BioLife Solutions Short-Term Capital Lease Obligation Historical Data

The historical data trend for BioLife Solutions's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Short-Term Capital Lease Obligation Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.92 2.57 2.85 1.18 1.44

BioLife Solutions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.76 2.62 2.80 1.44 1.70

BioLife Solutions Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


BioLife Solutions Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines